Raymond James & Associates’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
Other funds holding IMPV
EC
CS
WIC
GLAM
BCM
AAM
Raymond James & Associates's IMPV Position: Q4 2018 in Review
Raymond James & Associates sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 10,535 shares — an estimated $489K sold.
Raymond James & Associates first reported a position in IMPV in Q1 2016 and held it in 11 quarters. The position peaked at $1.13M in Q2 2017. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.
- Raymond James & Associates reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
- Raymond James & Associates sold 10,535 Imperva, Inc. shares in Q4 2018, an estimated $489K.
- Raymond James & Associates first reported a position in Imperva, Inc. in Q1 2016 and held it in 11 quarters.
- Raymond James & Associates's Imperva, Inc. position peaked at $1.13M in Q2 2017.
- 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.
Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.